Main results
We did not identify any randomised controlled trials that evaluated the effectiveness of sleep positioning systems on hip migration.
We did find two randomised cross-over trials that met the inclusion criteria in respect of secondary objectives relating to sleep quality and pain. Neither study reported any important difference between sleeping in sleep positioning systems and not for sleep patterns or sleep quality (two studies, 21 children, very low quality evidence) and pain (one study, 11 children, very low quality evidence). These were small studies with established users of sleep positioning systems and were judged to have high risk of bias.
We found no eligible trials that explored the other secondary objectives (number or frequency of hip problems, quality of life of the child and family, physical functioning, and adverse effects).
Authors' conclusions
We found no randomised trials that evaluated the effectiveness of sleep positioning systems to reduce or prevent hip migration in children with cerebral palsy. Nor did we find any randomised trials that evaluated the effect of sleep positioning systems on the number or frequency of hip problems, quality of life of the child and family or on physical functioning.
Limited data from two randomised trials, which evaluated the effectiveness of sleep positioning systems on sleep quality and pain for children with cerebral palsy, showed no significant differences in these aspects of health when children were using and not using a sleep positioning system.
In order to inform clinical decision-making and the prescription of sleep positioning systems, more rigorous research is needed to determine effectiveness, cost-effectiveness, and the likelihood of adverse effects.
P L A I N L A N G U A G E S U M M A R Y

Sleep positioning systems for children with cerebral palsy Background
Hip migration (where the top of the thigh bone gradually moves away from the pelvis) affects a substantial number of children with cerebral palsy and is often associated with pain. For some children with cerebral palsy, particularly those who are unable to walk, equipment is sometimes recommended to help children sleep in positions that reduce or prevent hip migration. This equipment is known as 'sleep positioning systems' and can be prescribed along with equipment designed to support posture while sitting or standing, or both, during the day. Together, these are referred to as 24-hour postural management programmes.
Families and health professionals need information about whether sleep positioning systems work in this way, to help them make decisions about their use.
Review question
The aim of this review was to look for robust evidence from randomised controlled trials evaluating the effectiveness of sleep positioning systems for children with cerebral palsy. Randomised controlled trials involve two groups of people; one of the groups receives the treatment (experimental group), while the other group does not (control group), and the results are compared. To ensure the groups are similar, deciding which group a person joins is based on chance (random), so that any differences in the results between groups, is due only to the treatment (INVOLVE Jargon Buster).
Study characteristics
We carried out a comprehensive search for studies. The evidence is current to December 2014.
Key results
No randomised controlled trials were found that evaluated the effectiveness of sleep positioning systems to reduce or prevent hip migration.
Two small randomised controlled trials compared children's quality of sleep when they were using and not using their sleep positioning system. One of these studies also examined pain when sleeping in and out of a sleep positioning system. These were cross-over trials (see Cochrane Glossary). The children in these studies spent a few nights using their sleep positioning system and then a few nights not using it, or the other way round. The order in which they either used or did not use the equipment was randomised.
Twenty-one children with cerebral palsy, aged between 5 and 16 years, who were used to sleeping in sleep positioning systems took part in the studies. One of the studies took place in a sleep laboratory and the other study took place in the children's homes. Neither study reported any differences in quality of sleep or pain whether using or not using their sleep positioning system. These results need to be interpreted cautiously due to the small numbers of children involved and the fact that the children who participated were already accustomed users of the equipment. There were also various weaknesses in the way the research was designed and reported.
Quality of the evidence
The quality of the current evidence regarding the effectiveness of sleep positioning systems for children with cerebral palsy is very low and more robust research is needed to help families and professionals make informed decisions about whether to use this intervention.
S U M M A R Y O F F I N D I N G S F O R T H E M A I N C O M P A R I S O N [Explanation]
Sleeping in a sleep positioning system compared with not sleeping in a sleep positioning system for children with cerebral palsy Population: Children with cerebral palsy Settings: United Kingdom (at home or in paediatric research laboratory) Intervention: Sleeping in sleep positioning system Comparison: Not sleeping in sleep positioning system Outcomes Impact Number of participants (studies)
Quality of the evidence (GRADE)
Reduce hip migration/hip problems 
B A C K G R O U N D Description of the condition
Cerebral palsy affects between 2 and 2.5 per 1000 children and is one of the most common causes of serious childhood physical disability (Stanley 2000) . The definition of cerebral palsy as reported by Rosenbaum 2007 is: "Cerebral palsy describes a group of permanent disorders of the development of movement and posture, causing activity limitation, that are attributed to non-progressive disturbances that occurred in the developing fetal or infant brain. The motor disorders of cerebral palsy are often accompanied by disturbances of sensation, perception, cognition, communication, and behaviour, by epilepsy, and by secondary musculoskeletal problems." The Surveillance and Cerebral Palsy in Europe group provides a system to classify the types of motor impairment as spastic, dyskinetic (dystonia and choreoathetosis), or ataxic (Cans 2000). Spastic types are further classified according to the distribution as either unilateral or bilateral. However, the terms 'hemiplegia' for unilateral involvement, 'diplegia' when lower limbs are more affected than upper limbs, and 'quadriplegia' for four-limb 'total body' involvement are also commonly used to describe the topography of spastic cerebral palsy. The severity of movement disability can be classified into one of five levels using the Gross Motor Function Classification System (GMFCS), which has demonstrated good reliability and validity (Palisano 1997). Children in Level I perform in sitting, standing and walking much as their age-matched peers, albeit with qualitative differences, while children in Level V have difficulty achieving head and trunk postures, and any voluntary control of movement due to their motor impairment. Hip displacement is common in children with cerebral palsy and can cause pain and loss of function, and have an effect on personal care (Cornell 1995) . Hip displacement refers to the migration of the femoral head laterally from under the acetabulum (Wynter 2008) . The amount of displacement is expressed as a migration percentage (hip migration). The risk of hip displacement, defined as an X-ray measured migration index of greater than 30%, increases linearly by GMFCS Level from negligible in Level I to almost universal in Level V; overall, hip displacement is estimated to affect about a third of children with cerebral palsy (Soo 2006) . The risk of scoliosis also appears to increase with greater movement disability (Saito 1998) and spinal deformity is often associated with hip problems (dislocation, dysplasia) and pelvic obliquity. Hip surveillance is a process using X-rays and clinical assessment to screen the hips of children to identify and monitor early indicators of progressive hip displacement. It has long been recommended for children with bilateral spastic cerebral palsy who are not walking by 30 months of age (Scrutton 1997) . Published guidelines in Australia advocate a more stringent screening programme for all children with cerebral palsy regardless of gross motor functional ability. The guidelines recommend repeated measures at specific intervals and include recommendations to monitor the hip status of a defined group of more severely-affected children with hemiplegia (Wynter 2008) . Surgical management of the hip is considered when the migration index exceeds 30%, and screening combined with early surgical intervention has been proposed to ameliorate hip dislocation (Hägglund 2005) . Non-surgical interventions that aim to prevent hip migration and displacement include botulinum toxin A or phenol injections to reduce the deforming forces caused by spastic muscles, and also positioning using orthoses and equipment to manage hip and body posture in sitting, standing and lying (NICE 2012 
Description of the intervention
Sleep positioning systems are commercially-available, individualised, lying support systems that may contain one or more component parts, which are held in position by a base layer or sheet (Polak 2009). These sleep positioning systems are available in different sizes and are made from a variety of materials, including special foams that conform to body shape or a series of straps that hold the body in a neutral and symmetrical position. The system applies or resists forces to maintain the posture, hence the forces must be applied over maximal surface areas available to minimise pressure, and materials should be such that temperature regulation is not compromised. The idea is that children sleep, positioned in this equipment, with the goal of maintaining one position overnight. While the primary focus of this review was the use of sleep positioning systems to prevent or reduce hip migration, they are also prescribed to improve sleep and provide comfort at night. 
Why it is important to do this review
It is unclear whether the provision of sleep positioning systems helps to prevent hip migration. As sleep positioning systems can create other problems for the child and family, and can be expensive to purchase and maintain, evidence of cost effectiveness is also crucially important. A study evaluating postural management programmes, including sleep positioning systems, suggested that children using postural management experienced fewer hip problems compared to historical controls (Pountney 2009). These authors identified that sleep positioning systems were the least used item of postural management equipment and suggested that this may have been due to families' reluctance to interfere with a child's sleep routine and increase night-time disturbance. A case series of children using sleep positioning systems identified that while most children adapted to using the equipment, some children were unable to sleep in the equipment, and a third left the study (Hankinson 2002) . Another survey indicated that many families encountered problems using the equipment and needed support and education, particularly in the early stages (Goldsmith 2000) . Sleep problems in children with developmental disabilities are much more common and severe than in children who do not have a developmental disability (Keenan 2007) , and anything that might interfere with sleep may not be well received by parents. The evidence for postural management programmes appears limited and it is thought that further research is needed (Pountney 2006) . Despite this, and the question of acceptability of sleep positioning systems, the prescription of this equipment is becoming increasingly widespread. It is therefore important to determine whether the provision of sleep positioning systems reduce or prevent hip migration, as well as examining the effects on associated outcomes such as sleep patterns, quality of life, and pain.
O B J E C T I V E S
To determine whether commercially-available sleep positioning systems, compared with usual care, reduce or prevent further hip migration in children with cerebral palsy. Any negative effect of sleep positioning systems on hip migration was considered within this objective.
Secondary objectives were to determine the effect of sleep positioning systems on: (1) number or frequency of hip problems; (2) sleep patterns and quality; (3) quality of life of the child and family; (4) pain; and (5) physical functioning. We also sought to identify any other adverse effects of sleep positioning systems for children with cerebral palsy.
Public involvement
Parent carers of children with disabilities contributed to this review by identifying the topic at a question-generation event using the structured Population-Intervention-Comparator-Outcome (PICO) format; subsequently parent carers helped to refine the research objectives, interpret the findings, and write the plain language summary. Parent carers were part of the 'Family Faculty', a group of parent carers who contribute to the research activities of the Peninsula Cerebra Research Unit (PenCRU) (pencru.org), a childhood disability research unit based in Devon, England. This review is based on a published protocol (Lloyd 2011), and has been prepared following the Cochrane Handbook (Higgins 2011c), and Standards for the reporting of new Cochrane Intervention Reviews (MECIR 2012).
M E T H O D S
Criteria for considering studies for this review
Types of studies
We searched for randomised controlled trials (RCTs). Randomised controlled trials are an experimental design where participants are randomly allocated into treatment or control groups. The following trials were eligible for inclusion:
• RCTs of sleep positioning systems versus usual care (which may include the use of support in seating and standing, botulinum toxin A, and surgery);
• RCTs comparing one sleep positioning system with another; and
• RCTs comparing sleep positioning with other postural management systems (e.g. seating or standing support).
Cross-over trials were considered as RCTs according to the guidelines in the Cochrane Handbook for Systematic Reviews of Interventions (Higgins 2011b).
Types of participants
Children and adolescents were defined as 18 years of age or younger (where at least 50% of the study population was 18 years of age or under), with a clinical diagnosis of cerebral palsy. We included children with all types (spastic, ataxic, dyskinetic/athetoid) and severity (GMFCS Levels I to V) of cerebral palsy. We only included trials that involved individuals with other diagnoses if the data for individuals with cerebral palsy could be extracted separately.
Types of interventions
Overnight use of any commercially-manufactured whole body sleep positioning system (such as Chailey Lying Support T M , Dreama T M , Sleepform ® , Moonlite/Moonlight T M , Symmetrisleep ® , Snooooooze T M ), applied in any setting (i.e. in the family home or in residential care). We excluded the use of sleep positioning systems in hospital (e.g. neonatal units). We also excluded studies evaluating seating and standing supports without sleep positioning systems, and studies evaluating orthoses worn at night if they were not designed for the whole body.
Types of outcome measures Primary outcomes
• Hip migration percentage as determined by frontal anteroposterior, plain film radiograph, which measures the percentage of the femoral head that lies outside the acetabulum (Thomason 2014). Standardised measurement over time enables improvement, deterioration or no change to be determined.
Secondary outcomes
• Number or frequency of hip problems (e.g. dislocations, dysplasia, surgical interventions).
• Sleep patterns or sleep quality (e.g. time taken to get to sleep, hours asleep, and number of awakenings as measured by polysomnography, Actigraph, parent-reported).
• Quality of life of child and family (as measured by standardised child-or parent-reported outcome measures such as Pediatric Quality of Life Inventory (PedsQL) cerebral palsy module, or Child Health Questionnaire (CHQ)).
• Pain (as measured by, for example, Paediatric Pain Profile (PPP)).
• Physical functioning (as measured objectively by a validated scale, such as the Gross Motor Function Measure (GMFM), or through interview-assessment such as Pediatric Evaluation of Disability Inventory (PEDI)).
• Adverse events (i.e. intolerability of sleep positioning systems (child-or parent-reported)).
The timing at which outcomes were measured was vital. We expected to see relevant outcomes reported at baseline and an appropriate time at follow-up. Hip migration might be plotted as trajectory based on annual or six-monthly X-rays, or follow-up after at least one or more years. Pain and sleep outcomes could be measured and compared over shorter periods such as weeks or months.
Search methods for identification of studies
We searched the following databases on 13 June 2012, 13 May 2014 and most recently on 3 December 2014. The searches were not limited by date, language, publication status or study design.
• Cochrane Central Register of Controlled Trials (CENTRAL; The Cochrane Library), 2014 Issue 12, and which includes the Specialised Register of the Cochrane Developmental, Psychosocial and Learning Problems Group.
• Ovid MEDLINE In-Process and Other Non-Indexed Citations, 1948 to December Week 48 2014.
• EMBASE (Ovid), 1974 to December Week 48 2014.
• CINAHL (Cumulative Index to Nursing and Allied Health Literature; EBSCOhost), 1981 to current.
• Cochrane Database of Systematic Reviews (CDSR; The Cochrane Library), 2014 Issue 12.
• Database of Abstracts of Reviews of Effects (DARE;The Cochrane Library), 2014 Issue 12.
• Health Technology Assessment Database (HTA; The Cochrane Library, 2014 Issue 12.
• NHS Economic Evaluation Database (EED; The Cochrane Library), 2014 Issue 2.
• BNI (British Nursing Index; ProQuest), 1994 to 3 December 2014.
• HMIC (Health Management Information Consortium; Ovid), 1979 to 3 December 2014.
• Conference Proceedings Citation Index -Science (CPCI-S; Web of Science), 1990 to 3 December 2014.
• Conference Proceedings Citation Index -Social Sciences & Humanities (CPCI-SSH; Web of Science), 1990 to 3 December 2014.
• PEDro (Physiotherapy Evidence Database; pedro.org.au), all available years.
• OTSeeker (Occupational Therapy Systematic Evaluation of Evidence; otseeker.com), all available years.
• Cochrane Methodology Register (CMR; The Cochrane Library), 2014 Issue 12.
• Clinicaltrials.gov (clinicaltrials.gov), all available years.
• World Health Organisation International Clinical Trials Registry Platform (ICTRP; who.int/ictrp/en), all available years.
• WorldCat (worldcat.org), all available years.
The search strategy combined terms for cerebral palsy with generic terms for sleep positioning systems or brand name products. The search strategies for each database are reported in Appendix 1. In addition, we searched the reference lists of all full-text papers retrieved to identify studies missed by the electronic searches. We contacted the manufacturers of sleep positioning systems and authors of relevant papers to ask if they were aware of any published and unpublished research. We also conducted a general Internet search using the search engine 'Google', using terms from the search strategy to capture any relevant grey literature.
Data collection and analysis
Methods archived for future updates of this review can be found in the Additional Methods Table in Appendix 2 and our protocol for this review (Lloyd 2011).
Selection of studies
Two authors (MR, SB) independently screened titles and abstracts of papers to identify records of potential eligibility. Where necessary, the full-text article was examined to determine relevance; two papers were translated for this purpose. Two independent review authors (SB and CM or SB and MR) then assessed each record for inclusion in the review using the inclusion criteria set out above. Where a review author was an author of a paper being considered for inclusion, two review authors not involved in that study assessed its eligibility. Disagreements were resolved through discussion and consultation with a third author (JTC or MR).
Data extraction and management
Two review authors (SB, CM) independently extracted the relevant data onto a data extraction form based on examples of forms used by National Institute for Health Research (NIHR) Collaboration for Leadership in Applied Health Research and Care, South West Peninsula (PenCLAHRC) and a Cochrane template. The review authors were not blinded to the study authors or journal when extracting the data. We planned to resolve any disagreements by discussion or with reference to a third person (GH) but no disagreements arose. Relevance of the outcomes assessed was discussed with two parent carers. The following data were extracted from all eligible trials.
• Study characteristics: Number of participants, inclusion and exclusion criteria, type of intervention and comparison, intervention characteristics (duration, frequency, setting, any training received by parents in the use of the sleep positioning system), and number of withdrawals.
• Participant characteristics: Gender, age, disease severity, and type of cerebral palsy (e.g. spastic, ataxic, dyskinetic/athetoid).
• Outcome measures assessed after finishing the intervention and at follow-up.
Assessment of risk of bias in included studies
Review authors assessed the methodological quality of each trial which met the inclusion criteria using the 'Risk of bias' tool described in the Cochrane Handbook for Systematic Reviews of Interventions (Higgins 2011a). Two review authors (SB, CM) assessed each study independently and resolved disagreements by discussion with each other. Judgements were based on answering a specific question for each domain (sequence generation, allocation concealment, blinding, incomplete outcome data, selective outcome reporting and other sources of bias), to which the answer 'yes' indicated a low risk of bias, and the answer 'no' indicated a high risk of bias. If insufficient detail was reported in the paper, the judgement was 'unclear' risk of bias. Samples of children with cerebral palsy in RCTs are often small and heterogeneous, so randomisation is unlikely to produce equal distributions of known or unknown determinants of outcome (Blair 2004) . The review authors considered the possibility of clinically-significant differences in baseline characteristics as another source of bias when assessing studies, by looking to see whether minimisation for characteristics such as age and hip migration status was applied at baseline to reduce group differences (Altman 2005). In line with Cochrane guidance, if one or more domains was judged to indicate a high risk of bias, the review authors assessed a study as having an overall high risk of bias (Higgins 2011a). We presented the findings of the 'Risk of bias' assessment in the 'Risk of bias' table (beneath the Characteristics of included studies  table) and provided a narrative description in the Risk of bias in included studies subsection.
Measures of treatment effect Continuous outcomes
Where the reported summary statistics varied (mean and standard deviation; or median and interquartile range), SB requested the raw data from the authors. JM then re-analysed the data, so that the same summary data could be reported across the studies. For primary outcomes, we reported the mean difference (MD) with 95% confidence intervals (CIs). Where a study had a large number of variables, we identified a limited set of key variables for each outcome in advance of statistical analysis (Altman 1991; Higgins 2011b) . This aimed to control the rate of false positive results and avoid use of adjustments for multiple comparisons, which make statistical tests more conservative. The chosen key variables included those measured by all of the included studies, and those which did not require the performance of laboratory investigations, and so have the potential to be more easily measured in future research. Whether they are the key variables that should be measured for the outcomes under consideration, is not the focus of this review.
Cross-over trials
For cross-over trials, we presented the results from paired t-tests. We considered a P value less than 0.05 to be statistically significant. For more information on additional methods archived for future updates of this review, please see Appendix 2 or Lloyd 2011.
Unit of analysis issues
No unit of analysis issues arose for this review. For more information on methods to overcome unit of analysis issues archived for future updates of this review, please see Appendix 2 or Lloyd 2011.
Dealing with missing data
Study authors provided the raw data from their studies to enable reanalysis. We collected the numbers of participants for whom no outcome data were obtained and reported this information in the 'Risk of bias' assessment.
Assessment of heterogeneity
There were insufficient trials to undertake an assessment of heterogeneity. For more information on methods to assess heterogeneity archived for future updates of this review, please see Appendix 2 or Lloyd 2011.
Assessment of reporting biases Outcome reporting bias
Where a study met the inclusion criteria, we examined the report of the study to assess for selective outcome reporting. We assessed the study as adequate if it met the following criteria.
• The study protocol was available and all of the study's prespecified (primary and secondary) outcomes that were of interest to the review were reported in the pre-specified way.
• The study protocol was not available, but it is clear that the published reports included all expected outcomes, including those that were pre-specified.
Publication and other reporting bias
We requested the start and end date of studies from the authors to consider time-lag bias. Where we received this information, we considered it in the 'Risk of Bias' assessment. There were too few included studies to enable other meaningful analysis. Please see Appendix 2 or Lloyd 2011 for additional methods for assessing publication and other reporting biases archived for future updates of this review.
Data synthesis
We planned to perform a meta-analysis or provide a descriptive review depending on the number of studies and the quality and type of data extracted. The decision of whether or not to carry out a meta-analysis was reached through consensus of three of the authors (SB, CM, JM). The criteria for our decision was by consideration of the methodological or clinical differences between the included studies (including: measurement tools, experimental location, choice of metric, age of participants, type of motor disorder, position adopted in sleep positioning system, history of seizures, GMFCS Level, and type of sleep positioning system). We concluded that it would be inappropriate to carry out a fixedeffect meta-analysis because the assumption of no between-study variation is implausible given the heterogeneity, and we rejected a random-effects meta-analysis because " [if ] there are few studies or if the studies are small, a random-effects analysis will provide poor estimates of the width of the distribution of intervention effects" (Deeks 2011 Section 9.5.4).
We present a narrative review of the results in the Effects of interventions section. This was produced consistently to include the same elements of information for each study, and presented in the same order. We only discussed patterns in the results in relation to the key variables for the outcomes of this review and only if significant differences were found. We presented the findings in Summary of findings for the main comparison in accordance with the recommendations of the Cochrane Handbook and the Grades of Recommendation, Assessment, Development and Evaluation (GRADE) approach for rating the quality of a body of evidence (Schünemann 2011). Using the GRADE approach, and a form based on a worksheet from the Cochrane Effective Practice and Organisation of Care (EPOC) group (EPOC 2015), we assessed the methodological design, risk of bias, inconsistency, indirectness, and imprecision of the evidence for the outcomes reported in this review.
Subgroup analysis and investigation of heterogeneity
Insufficient trials were available to enable us to consider statistical heterogeneity. Please see Appendix 2 or Lloyd 2011 for methods for conducting subgroup analyses archived for future updates of this review.
Sensitivity analysis
There were too few studies to enable us to perform these analyses. Please see Appendix 2 or Lloyd 2011 for methods for conducting sensitivity analyses archived for future updates of this review.
R E S U L T S Description of studies
See Characteristics of included studies, Characteristics of excluded studies, and Characteristics of ongoing studies.
Results of the search
The search results are presented in a PRISMA flow chart in Figure  1 . The initial search was carried out in June 2012 and followed by updated searches in May 2014 and December 2014. Our searches identified a total number of 1636 records, 1621 of which were retrieved by the electronic searches. Of the 37 full-text reports that were retrieved following title and abstract screening, 15 (41%) were found through contact with manufacturers and authors rather than through the electronic search. Although agreement on exclusion was 100%, several full-text reports could have been excluded for more than one reason (i.e. were both an ineligible intervention and an ineligible study design) (see Excluded studies). In sum, we excluded 34 reports, identified one ongoing study from one report (UKCRN ID 10914), and included two studies (from two reports). 
Included studies
We found no RCTs that evaluated the effectiveness of sleep positioning systems to reduce or prevent hip migration. Two cross-over studies (involving 21 children in total) met our inclusion criteria in respect of two secondary objectives: sleep quality and pain (Hill 2009; Underhill 2012) . Both studies, conducted in Southern England, used randomised order of treatment (sleeping in sleep positioning systems or not sleeping in sleep positioning systems). Participants in both trials were children (12 boys, 9 girls in total) with cerebral palsy, graded as Levels III to V according to the GMFCS; aged 5 to 16 years; and established users of sleep positioning systems. The Hill 2009 study, which the authors described as a pilot, was conducted in a laboratory (one night with and one night without sleeping in sleep positioning systems, with at least three nights at home in between). Underhill 2012 was conducted in the child's home (four consecutive nights each sleeping with or without sleep positioning systems). Neither study reported the effects on hip migration. Hill 2009 measured outcomes in relation to sleep quality using polysomnography and video recording. Underhill 2012 assessed sleep quality by Actigraph and pain by parent-report using the PPP. While neither study explicitly set out to measure harms or adverse effects, the outcomes measured were capable of showing negative and positive effects. Further details about these studies are provided in the Characteristics of included studies tables.
Excluded studies
Of the 37 full-text articles retrieved, 11 were descriptive papers, and 7 did not look at either sleep positioning systems, cerebral palsy, or whole body sleep positioning systems (i.e. they focused instead on upper limb splints worn at night). Fifteen studies (from 16 reports), which did assess the interventions of interest but were not RCTs and therefore did not meet our inclusion criteria are listed in the Characteristics of excluded studies. Two of these reports refer to the same study (Polak 2007) .
Ongoing studies
We found one ongoing exploratory study, which would meet the criteria for inclusion into this review. No outcome data were available at the time of writing. For further information about this study, please see Characteristics of ongoing studies.
Risk of bias in included studies
Both included studies were judged to have a high risk of bias overall. See Figure 2 and Characteristics of included studies. 
Random sequence generation
Neither included study reported how the researchers generated the allocation sequence to each treatment condition (Hill 2009; Underhill 2012).
Allocation
Hill 2009 used a sealed-envelope method and was considered at low risk of bias, while Underhill 2012 did not report how random allocation to the sequence of treatments was concealed.
Blinding
No information is provided as to who did the polysomnography or Actigraph outcomes assessments, nor the training or expertise of those who completed it, in either of the included studies. While blinding of the delivery of this intervention was not possible in the included studies, a lack of blinding may have impacted the subjective outcomes that were not measured by technology (scores on the PPP and the video recording) (Wood 2008). Neither Hill 2009 or Underhill 2012 clearly described how analysts conducting the outcome assessment were blinded to group assignment.
Incomplete outcome data
Twenty-one children in total were randomised to take part in the included trials, but results are only available for 19 children. Both studies provided details of exclusions from analysis. Hill 2009 excluded one child due to pyrexial illness on the second study night and only one rapid eye movement (REM) cycle being recorded. In the Underhill 2012 study, sleep data were not available for one child as the Actiwatch failed. Another child only slept without the sleep positioning system for two of the four intended nights 'due to a severe reaction', but their results are included in the analysis, without explanation as to how the data were managed. Also, no reasons were provided for the lack of pain scores for one of the children.
Selective reporting
Authors of both included studies planned to assess other outcomes specified in their protocol, which were then not reported. Hill 2009 planned to assess day-time function using the Cambridge Neuropsychological Testing Battery (CANTAB). Underhill 2012 planned to assess number of night awakenings that lasted longer than five minutes and percentage of the sleep period which was motionless. Results for these outcomes were not reported. 
Other potential sources of bias
Both trials were of very short duration and performed under 'experimental' rather than pragmatic conditions. Hill 2009 had a washout period of a minimum of three nights, but the length of time between the two conditions (sleeping or not sleeping in sleep positioning systems) was not clear in Underhill 2012. Thus, the risk of effects from one condition affecting the other cannot be ruled out.
As the children were all established users of sleep positioning systems, it is also important to consider any possible effect of the order of conditions (whether the children slept in their sleep positioning system first or second). While Hill 2009 tested for a first-night effect and concluded that randomisation had adequately controlled for period effects, no test was made for these period effects in the Underhill 2012 trial. In order for the data to be collected from one location only in the Underhill 2012 trial (children in residential settings often go home at the weekends), data were only collected for four nights. However, as the authors report, Actigraph data are recommended to be collected from a minimum of five nights. Neither trial recruited the number of children needed for statistical power as per their protocol. Both trials recruited existing users of sleep positioning systems, which limited the generalisability of the results to new users of sleep positioning systems, as the children in these studies were likely to have adapted to their use. In the Hill 2009 trial, only 10 of the 22 children initially thought to be eligible actually participated. Children were excluded if they experienced uncontrolled nocturnal seizures, or by their own clinicians on the basis of unsettled domestic situations or extreme behavioural problems. This may have reduced the applicability of the results to those with more complex health conditions or social circumstances, or both.
Effects of interventions
See: Summary of findings for the main comparison
Primary outcomes Hip migration percentage
No included studies evaluated whether sleep positioning systems reduce or prevent hip migration in children with cerebral palsy.
Secondary outcomes Number or frequency of hip problems
No included studies evaluated whether sleep positioning systems reduce or prevent hip problems in children with cerebral palsy.
Sleep patterns or sleep quality
Both included studies measured sleep quality. Hill 2009 presented multiple variables (n = 18) for measuring sleep quality and carried out Bonferroni adjustments of the significance level to correct for multiple comparisons. We defined the key variables we thought most closely fit the objectives of this review and would also be comparable to variables measured by Underhill 2012. These were sleep latency and sleep efficiency. We have reported the results of paired t-tests for treatment effect for these key variables in Table  1 . As we included very few key variables, we did not make any adjustments to the significance level.
Sleep latency
Both included studies measured the time it took for the child to fall asleep once put to bed (latency). In both studies, one child fell asleep before the intervention commenced (bedtime). In the study reported by Underhill 2012, this child's data were excluded from the analysis; in Hill 2009, the nil score (asleep at the point recording began) was included in the analysis on the basis of intention-to-treat (ITT). In order to enable comparison, the results for Hill 2009, both including the nil score and without it, are set out in Table 1 . Neither study found a statistically significant difference in the time it takes for a child to fall asleep whether sleeping in the sleep positioning system or not.
Sleep efficiency
Both included studies also measured the percentage of time the child was actually asleep in bed (efficiency). Neither study reported a statistically significant difference whether sleeping in the sleep positioning system or not. Both included studies reported substantial individual variability. As the Underhill 2012 data provided to us contained a sequence of treatments, we carried out additional t-tests for a period effect (Altman 1991). We found no significant difference for sleep efficiency (t value = 0.67, P value = 0.52) or sleep latency (t value = 2.01, P value = 0.08). Hill 2009 tested for first-night effects and also reported no significant differences between the nights studied.
No statistical difference was reported between sleeping in the sleep positioning system or not in respect of any of the other 16 sleep quality variables measured by the included studies. Summary statistics, which we calculated from raw data provided by study authors, are presented in Table 2 .
Quality of life of child and family
No studies meeting the inclusion criteria examined the impact of sleep positioning systems on the quality of life of the child and family.
Pain
One included study -Underhill 2012 -measured the impact of sleep positioning systems on pain using the PPP. Parent-reported pain scores for the children were recorded following four nights in a sleep positioning system and compared to parent-reported pain scores recorded following four nights out of the sleep positioning system. The difference in pain scores of children sleeping in sleep positioning systems compared to those sleeping without was not statistically significant (see Table 1 ).
Physical functioning
No studies meeting the inclusion criteria explored the impact of sleep positioning systems on physical functioning.
Adverse effects
Neither included study reported on any adverse effects.
D I S C U S S I O N Summary of main results
We found no RCTs that examined the effectiveness of sleep positioning systems to reduce or prevent hip migration for children with cerebral palsy (see Summary of findings for the main comparison). Very low quality evidence (two small randomised cross-over studies) found no differences in sleep quality or pain between using a sleep positioning system or not, for existing users of sleep positioning systems. These findings need to be interpreted cautiously and are difficult to generalise due to the high risk of bias and low statistical power of these studies. We found no studies meeting our inclusion criteria that assessed possible adverse effects of sleep positioning systems, or the impact of sleep positioning systems on physical functioning, the number or frequency of hip problems, or the quality of life of the child and family.
Overall completeness and applicability of evidence
We found insufficient high quality evidence to address the objectives of this review. There is currently no robust research evidence to inform clinical decision-making regarding the prescription of sleep positioning systems to reduce or prevent hip migration for children with cerebral palsy. The use of sleep positioning systems can be affected by many different factors relating to (1) the equipment (availability, cost, size, appearance, hygiene, temperature control, and transportability); (2) experience, skills, and training of therapists and carers; (3) changing needs of the child; and (4) availability of alternative interventions (Polak 2007) . Adverse effects appear underreported, perhaps because, in these instances, the equipment is usually abandoned (Humphreys 2012; Pountney 2009); this key outcome should be recorded and reported. Inability to adhere to using sleep positioning systems is often assumed to be due to insufficient skill or confidence on the part of carers, leading to a focus on better training, but there are likely to be many other reasons, including perceived discomfort and temperature regulation (Innocente 2014). Both included and excluded studies reported that children withdrew for reasons such as illness or a need for other treatments. In some of the studies which did not recruit existing users of sleep positioning systems, and were excluded for methodological reasons, authors reported that some children also withdrew, as their carers said the children could not sleep properly when using their sleep positioning system. The included studies recruited children who were established users of sleep positioning systems and so provided no evidence as to the principles used to identify appropriate children for sleep positioning systems, nor the reasoning for the type of sleep positioning system used by the children. As these factors could have an influence on the outcomes measured, it is important that this is explored and documented in future research. Despite the prescription of sleep positioning systems, there is little evidence either regarding effectiveness or how best to choose which children are most likely to benefit. We also have no high quality evidence to judge whether commercial sleep positioning systems are more effective at reducing or preventing hip migration than using cushions and pillows to aid positioning at night, which have long been recommended by therapists (Bower 2008).
Quality of the evidence
The overall quality of evidence is very low. This review only found two RCTs, including a total of 21 children, which examined the effects of the intervention on two of the secondary objectives of this review (pain and sleep patterns/quality). Both were judged to have a high risk of bias and inadequate power related to small samples and substantial individual variability in the outcomes assessed. The restriction of the study sample to existing users of sleep positioning systems limits the applicability of the evidence to the general population of children with cerebral palsy. The applicability of the data from the study conducted by Hill 2009 is reduced further as this was carried out under laboratory conditions rather than in the children's homes.
Potential biases in the review process
Assessments for inclusion, risk of bias, and data extraction were carried out independently by two review authors. Authors of the included studies provided raw data and answered questions about how the data had been analysed (on the basis of intention-totreat or not), which enabled more comprehensive appraisal of the methods and findings. Two authors (CM, GH) are part of a current pilot RCT described in the Characteristics of ongoing studies and one of these authors (GH) is also the author of an excluded study. We avoided any potential conflict of interest by ensuring candidate papers were not reviewed by the authors of these papers. While the searches of the electronic databases were comprehensive, a relatively high proportion of potential references -15/37 (41%) -were found through contact with manufacturers and authors rather than through the electronic searches. Seven reports were not published and three papers were published in journals not indexed by the electronic databases, which highlights the importance of using supplementary search methods. It is therefore possible that other studies have been conducted but were not found, although it is unlikely that they these would be large RCTs that would change the conclusions of the review.
Agreements and disagreements with other studies or reviews
In line with two other published reviews on sleep positioning systems for children with cerebral palsy (Bush 2013; Wynn 2009), we concluded that there is limited evidence available of effectiveness to prevent deformity. As Montero 2014 reported in their review of studies looking at the technical devices used by children with motor disabilities, the methodological quality of the available evidence is low. By highlighting the lack of well-designed RCTs, this review challenges an assumption reported in studies (Dawson 2013; Hill 2009) , that sleep positioning systems are a proven, effective treatment to reduce or prevent hip migration. A consensus statement produced in 2006 proposed that a programme of rigorous research to evaluate sleep positioning systems was needed (Gericke 2006), but we found no evidence of studies likely to provide definitive evidence.
A U T H O R S ' C O N C L U S I O N S Implications for practice
Recent guidance from the National Institute for Health and Care Excellence (NICE) recommended that consideration be given to using 24-hour postural management strategies to prevent or delay the development of contractures or skeletal deformities (NICE 2012). However, this review provides no robust evidence of effectiveness or cost-effectiveness of commercial sleep positioning systems to guide decision making for families and clinicians.
Sleep positioning systems are suggested to address a range of issues.
In the absence of research evidence, it is important that families do not feel pressured to use or continue with sleep positioning systems, especially if it disrupts their lives. Equally, it is important to support families in persevering, if it is something they wish to pursue.
As sleep positioning systems are expensive and frequently abandoned, occupational therapists and physiotherapists need further, specific clinical guidance about how to assess who might be appropriate and which system to recommend over another, if at all. As the children typically prescribed sleep positioning systems (GM-FCS Level IV or V) are often unable to express feelings of discomfort or pain (Gough 2009), careful consideration should be given to how to assess the effects for individual children. Routine audit of provision of sleep positioning systems may help identify which children benefit from, and why children and families abandon using this equipment.
Implications for research
This review highlights the need for rigorously conducted RCTs to assess the effectiveness and cost-effectiveness of sleep positioning systems for children with cerebral palsy, and provide robust evidence to inform clinical practice.
The conduct of such studies would be facilitated by the development of an agreed set of appropriate and robust measures to assess the outcomes, including potential adverse events, perceived to be of importance to families and health professionals. The focus of this review was the use of sleep positioning systems as a conservative treatment to reduce or prevent hip migration. Whilst we also considered other secondary outcomes, future research on sleep positioning systems may broaden the scope to reduction or prevention of other joint deformities (e.g. knee), loss of passive joint range of motion and muscle contractures generally, comfort in lying, and/or risk of aspiration. Sleep positioning guidelines advise caution for children with respiratory problems and those at risk of aspiration (Polak 2009 The use of sleep positioning systems as part of 24-hour postural management can be considered a complex intervention (Craig 2008) . Therefore, the therapeutic programme should be documented in detail in a manual, and fidelity to the prescribed instructions should also be assessed as adherence as part of any trial. It will also be important for such studies to investigate any factors that create difficulties or lead families to stop using the equipment, such as when children sleep in different locations. The findings and recommendations from the NIHR-funded pilot study (in progress; UKCRN ID 10914) may provide further information to inform the design of trials in this area.
Given the population for whom such interventions are most likely to be recommended, it will be important to consider the potential interaction with other forms of postural management equipment (such as those designed to support the spine), as well as other medical technologies (such as those for respiratory assistance while sleeping), and coexisting conditions such as gastroesophageal reflux.
In the face of a lack of high quality evidence, it may be appropriate to consider n-of-1 trials (single-subject clinical trials) to help inform decisions for individual children. A meta-analysis of multiple n-of-1 trials could then explore trends in the data, which might identify the characteristics of children who respond, and any side effects (Lillie 2011; Sedgwick 2014).
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C H A R A C T E R I S T I C S O F S T U D I E S Characteristics of included studies [ordered by study ID]
Hill 2009
Methods Within subject, cross-over study with randomised order of treatment using sealed envelopes. 2 nights attended polysomnography in paediatric research laboratory. Study ran from January to • Established sleep system users Excluded Children with poorly controlled/uncontrolled nocturnal seizures, unsettled domestic situations, and extreme behavioural problems
Interventions
• 1 night, children slept in their own sleep positioning system (9 x Symmetrisleep, 1 x Jenx Dreama), and 1 night, children slept in a bed with cot sides and no postural support
• Each treatment was separated by at least 3 nights of sleep at home • Parent carers also completed sleep diaries, Chailey Sleep Questionnaire, and brief interviews at the end of each data collection period
Notes
Funded by Nancie Finne Charitable Trust, which is now administered by the Chartered Society of Physiotherapy (CSP) Charitable Trust 
Risk of bias
D A T A A N D A N A L Y S E S
This review has no analyses. 
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